Murillo's-bark

Quillaja saponaria

奎拉尔皂荚(又称肥皂树)是南美洲土著传统医学中使用的草药。该植物在不同文化中的特定传统用途尚未广泛记录。科学证据主要集中在它在疫苗开发和饲料添加剂方面的潜在应用上。研究使用了奎拉尔皂苷,特别是QS-21,以引发免疫反应并为某些病原体(如日本脑炎病毒JEV)提供保护性免疫力的小鼠提供保护。虽然通过克隆造林进行的QS-21生物合成显示出大规模生产的前景,但当前证据仅限于实验室环境。尚未记录重大安全问题或药物相互作用,但仍需进一步研究以全面了解其更广泛的应用和潜在影响。

速览
最佳证据
D
注意事项

仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同,请查阅所引来源。

科学怎么说

  • 该研究回顾了QS皂苷的生物合成,特别是QS-21,强调其在疫苗佐剂和微生物生产策略中的潜在应用。 D PMID
  • 该研究开发了一种使用HPLC-QToF-MS的测试方法来确认禽类饲料中是否存在Quillaja皂苷,并检测到Madhuca皂苷掺假。 D PMID
  • 由CoPoP介导的颗粒化与QS-21刺激结合,在小鼠中引发了强大的T细胞反应并提供了对JEV挑战的保护性免疫。 D PMID
  • 研究表明,尽管野生收获可以支持千克规模的QS-21纯化,克隆造林可能是满足日益增长的佐剂需求最实用和可扩展的战略。 D PMID

Frequently asked questions

What is Murillo's-bark?

Murillo's-bark (Quillaja saponaria) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.

What does the scientific evidence say about Murillo's-bark?

4 sourced findings are recorded for Murillo's-bark; the strongest carries evidence grade D. For example: 该研究回顾了QS皂苷的生物合成,特别是QS-21,强调其在疫苗佐剂和微生物生产策略中的潜在应用。

How strong is the evidence for Murillo's-bark?

The strongest finding for Murillo's-bark carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).

Is Murillo's-bark safe? What are the side effects?

No major safety issues are recorded for Murillo's-bark in our sources, but the data may be incomplete. Consult a qualified professional before use.

Does Murillo's-bark interact with medications?

No drug interactions are recorded for Murillo's-bark in our sources. This does not rule them out — check with a pharmacist.

What are the common names of Murillo's-bark?

Murillo's-bark is also known as: Квиллайя мыльная.

Is Murillo's-bark a proven treatment?

No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.

来源

  1. T2 The challenge of one billion adjuvanted vaccine doses: evaluating scalability, sustainability, and supply capacity of Quillaja saponin QS-21 for large-scale vaccine demand. literature abstract metadata
  2. T2 Recombinant Japanese Encephalitis Virus Envelope Antigen Presented on CoPoP Liposomes Elicits Cellular Immunity and Protects Mice From Lethal Challenge. literature abstract metadata
  3. T2 Advances in the heterologous biosynthesis of QS saponins: a review. literature abstract metadata
  4. T2 A confirmation test for the presence of Quillaja saponin and adulteration with Madhuca saponin in poultry feed using high-performance liquid chromatography and quadrupole time-of-flight mass spectrometry. literature abstract metadata